Getco Appoints Former UBS Exec as CEO

Getco LLC has announced the appointment of Daniel Coleman as its CEO, effective immediately.
Coleman was previously serving as the company's global head of equities and client services. As part of the reshuffle, co-founder Stephen Schuler will assume the role of executive director. Prior to Getco, Coleman held senior-level positions at UBS, as its global head of equities and as a sitting member of both the investment bank's executive committee and UBS AG's group managing board.
"Daniel is perfectly aligned with our long-term vision of utilizing technology to transform how investors transfer risk," says Getco Co-Founder Dan Tierney. "His unique combination of professional experiences, leadership ability and business acumen make him the ideal leader for the next stage of our growth."
Coleman will renew the firm's focus on its risk transference strategy, as well as engaging in new markets. The appointment marks a growth and opening of the once-secretive high-frequency trading firm, in light of regulatory reform and incoming restrictions on banks such as the Volcker Rule. During his previous role at the firm, Coleman oversaw initiatives such as Getco Execution Services, which provides algorithms and execution to clients, as well as its designated market maker operation, which is now the second-largest at the New York Stock Exchange.
"When I joined Getco, I was on a personal mission to find a firm that was at the forefront of trading and technology, as well as focused on improving the markets for all investors," says Coleman. "Stephen and Dan built an amazing firm that has been a catalyst for positive change in the financial markets for the last 12 years. Getco's Associates are some of the most passionate and talented professionals I have had the pleasure of working with, and I look forward to building upon this tradition of excellence and innovation."
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: https://subscriptions.waterstechnology.com/subscribe
You are currently unable to print this content. Please contact info@waterstechnology.com to find out more.
You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.
Copyright Infopro Digital Limited. All rights reserved.
As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (point 2.4), printing is limited to a single copy.
If you would like to purchase additional rights please email info@waterstechnology.com
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (clause 2.4), an Authorised User may only make one copy of the materials for their own personal use. You must also comply with the restrictions in clause 2.5.
If you would like to purchase additional rights please email info@waterstechnology.com
More on Emerging Technologies
BlueMatrix acquires FactSet’s RMS Partners platform
This is the third acquisition BlueMatrix has made this year.
Waters Wavelength Ep. 331: Cresting Wave’s Bill Murphy
Bill Murphy, Blackstone’s former CTO, joins to discuss that much-discussed MIT study on AI projects failing and factors executives should consider as the technology continues to evolves.
FactSet adds MarketAxess CP+ data, LSEG files dismissal, BNY’s new AI lab, and more
The Waters Cooler: Synthetic data for LLM training, Dora confusion, GenAI’s ‘blind spots,’ and our 9/11 remembrance in this week’s news roundup.
Chief investment officers persist with GenAI tools despite ‘blind spots’
Trading heads from JP Morgan, UBS, and M&G Investments explained why their firms were bullish on GenAI, even as “replicability and reproducibility” challenges persist.
Wall Street hesitates on synthetic data as AI push gathers steam
Deutsche Bank and JP Morgan have differing opinions on the use of synthetic data to train LLMs.
A Q&A with H2O’s tech chief on reducing GenAI noise
Timothée Consigny says the key to GenAI experimentation rests in leveraging the expertise of portfolio managers “to curate smaller and more relevant datasets.”
Etrading wins UK bond tape, R3 debuts new lab, TNS buys Radianz, and more
The Waters Cooler: The Swiss release an LLM, overnight trading strays further from reach, and the private markets frenzy continues in this week’s news roundup.
AI fails for many reasons but succeeds for few
Firms hoping to achieve ROI on their AI efforts must focus on data, partnerships, and scale—but a fundamental roadblock remains.